Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited

4502

Kedudukan dalam Saham #378
Takeda Pharmaceutical Company Limited is a global biopharmaceutical enterprise... Takeda Pharmaceutical Company Limited is a global biopharmaceutical enterprise engaged in the discovery, development, manufacturing, marketing, and out-licensing of various medical products. The company's operations span Japan, the United States, Europe, Canada, Latin America, Russia, and other regions across Asia and internationally. Takeda concentrates its efforts on key therapeutic areas such as gastroenterology, rare diseases, plasma-derived therapies, oncology, and neuroscience. Its extensive product range includes well-known brands like Entyvio, Takhzyro, Velcade, and Vyvanse. To advance its pipeline and innovation, Takeda actively fosters numerous collaborations, in-licensing agreements, research partnerships, and strategic alliances with a diverse array of organizations, including academic institutions like the University of Texas MD Anderson Cancer Center and biotech firms such as Neurocrine Biosciences, Inc. and Arrowhead Pharmaceuticals Inc. Established in 1781, the company maintains its headquarters in Tokyo, Japan.
Harga Saham
$40.26
Modal Pasaran
$64.06B
Perubahan (1 hari)
0.71%
Perubahan (1 tahun)
42.44%
Negara
JP
Perdagangan Takeda Pharmaceutical Company Limited (4502)

Kategori

Healthcare
Bilangan saham terbitan bagi Takeda Pharmaceutical Company Limited (4502)
Bilangan saham terbitan setakat October 2026: 0
Menurut laporan kewangan terkini dan harga saham Takeda Pharmaceutical Company Limited, bilangan saham terbitan semasa ialah 0. Pada akhir October 2026, syarikat mempunyai 0 saham terbitan. Bilangan saham terbitan biasanya dipengaruhi oleh pecahan saham dan pembelian balik saham.
Sejarah saham terbitan untuk Takeda Pharmaceutical Company Limited (4502) dari 2026 hingga 2026
Saham terbitan pada akhir setiap tahun
Tahun Saham Terbitan Ubah
Tidak cukup data untuk tarikh yang disediakan.
Saham terbitan bagi syarikat atau pesaing yang serupa